- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hypera SA (HYPE3)
29.08
+0.71(+2.50%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
28.19
29.38
52 wk Range
26.54
37.29
HYPE3 Scorecard
Full Analysis
Valuation implies a strong free cash flow yield
High dividend Yield
"Hypera SA stock price live, this page displays OTC HYPMY stock exchange data. View the HYPMY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hypera SA real time stock price chart below.
What Is the Hypera SA Stock Price Today?
The Hypera SA stock price today is 29.08.
What Is the Stock Symbol for Hypera SA?
The stock symbol for Hypera SA is ""HYPMY.""
What Stock Exchange Does Hypera SA Trade On?
Hypera SA is listed and trades on the OTC Markets stock exchange.
Is Hypera SA a Good Stock to Buy?
Determining whether Hypera SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HYPMY quote. (ISIN: US44914U1060)"
What Is the Hypera SA Stock Price Today?
The Hypera SA stock price today is 29.08.
What Is the Stock Symbol for Hypera SA?
The stock symbol for Hypera SA is ""HYPMY.""
What Stock Exchange Does Hypera SA Trade On?
Hypera SA is listed and trades on the OTC Markets stock exchange.
Is Hypera SA a Good Stock to Buy?
Determining whether Hypera SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HYPMY quote. (ISIN: US44914U1060)"
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
28.1929.38
52 wk Range
26.5437.29
UnlockHYPE3 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low earnings multiple
- HYPERMARCAS ON NM receives Investment Bank Analyst Rating Update
- Investing.com
Pro - HYPERMARCAS ON NM receives Investment Bank Analyst Rating Update
- Investing.com
Pro - HYPERMARCAS ON NM receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- HYPERMARCAS ON NM receives Investment Bank Analyst Rating Update
- Investing.com
Pro - HYPERMARCAS ON NM receives Investment Bank Analyst Rating Update
- Investing.com
Pro - HYPERMARCAS ON NM receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Hypera SA Company Profile
Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, pleased, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, Luna, moon, Lydian, macrodantin, MaxSulid, Milgamma, Mioflex – A, Nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, Softalm, Tacroz, Tinodin, Umma, and velunid brands. The company also provides sun protection and moisturizing skin care products under the Mantecorp Skincare brands; similar products under the Doralgina, Dropy D, Equilibrisse, balance, Flavonid, Histamin, neofresh, neolefrin, neoquimica Vitamins, Neosorum, and Torsilax brands; and over-the-counter drugs under the Apracur, Benegrip, Buscopan, Coristina D Pro, Engov, Epocler, Estomazil, and Neosaldina brands, as well as similar and generic drugs under the Neo Química brand. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Biotônico Fontoura, and Zero-Cal brands; and generic medicines under the Hydroxyzine, Sodium Diclofenac, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brands. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 1999 and is headquartered in São Paulo, Brazil.
Compare HYPE3 to Peers and Sector
Metrics to compare | HYPE3 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHYPE3PeersSector | |
|---|---|---|---|---|
P/E Ratio | 10.9x | 8.3x | −0.6x | |
PEG Ratio | −4.64 | 0.17 | 0.00 | |
Price/Book | 1.5x | 1.1x | 2.6x | |
Price / LTM Sales | 2.3x | 1.5x | 3.1x | |
Upside (Analyst Target) | 27.2% | 32.5% | 55.8% | |
Fair Value Upside | Unlock | 19.3% | 7.3% | Unlock |
FAQ
What Is the Hypera ON (HYPE3) Stock Price Today?
The Hypera ON stock price today is 29.08
What Stock Exchange Does Hypera ON Trade On?
Hypera ON is listed and trades on the B3 stock exchange.
What Is the Stock Symbol for Hypera ON?
The stock symbol for Hypera ON is "HYPE3."
Does Hypera ON Pay Dividends? What’s The Current Dividend Yield?
The dividend yield is 4.46%.
What Is the Hypera ON Market Cap?
As of today, Hypera ON market cap is 18.39B.
What is Hypera ON Earnings Per Share?
The Hypera ON EPS is 2.67.
What Is the Next Hypera ON Earnings Date?
Hypera ON will release its next earnings report on 05 Nov 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.